Biden wants a drug pricing plan in 45 days. Who’s going to write it?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Category: dementia
STAT+: Medicare starts process that could limit access to Biogen’s new Alzheimer’s drug
WASHINGTON — Federal officials on Monday announced the agency will start a process that could…
Powerful House Democrats demand documents from Biogen about coordination with FDA on new Alzheimer’s drug
WASHINGTON — Two powerful House Democrats on Monday demanded documents from Biogen about the approval…
.jpg)
FDA calls for federal investigation into its controversial Alzheimer’s drug approval
The head of the Food and Drug Administration has called for a wide-ranging federal investigation…
STAT+: FDA’s expansive Alzheimer’s drug approval surprised even top agency officials
WASHINGTON — The Food and Drug Administration’s contentious decision to approve a new Alzheimer’s drug…
Listen: Aduhelm’s latest twist, how Covid variants are shaping the summer, & a digital health boom
How worrying is the Delta variant? Is there a digital health bubble? And what is…
STAT+: Is the Alzheimer’s Association really pushing Biogen to lower its new drug’s price — or is it lip service?
WASHINGTON — The Alzheimer’s Association stunned Washington last month when it urged Biogen to lower…
Listen: A CRISPR milestone, Biogen’s FDA saga, & George Yancopoulos on biotech in 2021
How much can CRISPR really do? Has the FDA been totally honest? And is it…
Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug
WASHINGTON — Former health secretary Donna Shalala called for a federal investigation into the Food…
STAT+: Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug
It was perhaps the most contentious drug approval in decades, shocking drug company executives, insurance…
Will Biogen’s new Alzheimer’s drug’s burden on Medicare be big, huge, or catastrophic?
The Food and Drug Administration’s decision to grant wide-ranging approval to the controversial, pricey new…
STAT+: House leaders to investigate FDA approval and price of Biogen’s Alzheimer’s drug
WASHINGTON — The top House Democrats on two powerful committees on Friday announced an investigation…
Listen: FDA inner workings, GSK’s foggy future, & the alarming rise in colorectal cancer
How does the FDA handle unprecedented decisions? What’s it like to go on “Good Morning…
STAT+: FDA’s Woodcock is just ‘not that concerned’ about the criticism over Biogen’s Alzheimer’s drug, Aduhelm
WASHINGTON — The Food and Drug Administration has been without a permanent commissioner for six…
.jpg)
A crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
For families and physicians grappling with the historic approval this month of the controversial Alzheimer’s…
Newsbites: Inflammatory gut microbes; Vitamin D; Dementia
Food Choices May Increase Inflammatory Gut Microbes The bacteria that live in our gut have…
Frontline: Risk of dementia; Risk of falls: Decrease gut inflammation
Getting Enough Sleep May Cut Your Risk of Dementia People in their 50s and 60s…
STAT+: Bipartisan pair of senators calls on Congress to examine expensive new Alzheimer’s drug
WASHINGTON — Sens. Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) want Congress to take a…
STAT+: Biogen isn’t the only drug company that will profit from the new Alzheimer’s drug Aduhelm
WASHINGTON — Biogen’s expecting to make billions from its newly approved Alzheimer’s drug Aduhelm. But…
STAT+: Athira Pharma CEO placed on leave amid allegations of altered images in her research papers
The chief executive of Athira Pharma, a biotech developing treatments for Alzheimer’s and other neurodegenerative…
Listen: The Covid vaccine booster debate, 23andMe hits Wall Street, & biotech’s call of the decade
Is 23andMe a tech company? Do we really need booster shots of Covid-19 vaccines? And…
Opinion: Why a controversial decision won’t stop me from serving on FDA advisory committees
Last week’s controversial decision by the FDA to give aducanumab, Biogen’s Alzheimer’s drug, accelerated approval…
Opinion: Listen: Two Alzheimer’s experts with opposing viewpoints on Aduhelm
This week’s “First Opinion Podcast” is a special two-part episode focusing on the controversial —…
Opinion: 6 ways the FDA’s approval of Aduhelm does more harm than good
Like many people, I was shocked when the Food and Drug Administration ignored the advice…
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
Their phones are ringing off the hook and their email inboxes are filling up with…
STAT+: ‘Simply unacceptable’: Alzheimer’s Association blasts Biogen over the price of its new medicine
In harsh tones, the Alzheimer’s Association sharply criticized Biogen (BIIB) for the $56,000 price tag…
STAT+: Advocates blast the FDA for not moving as fast on ALS as on Alzheimer’s
WASHINGTON — The Food and Drug Administration fast-tracked Biogen’s divisive Alzheimer’s drug Aduhelm, but it’s…
Listen: Every angle on the FDA’s polarizing approval of Biogen’s Alzheimer’s drug
Was the FDA right to approve Aduhelm? What’s a fair price for a debatable drug?…
STAT+: Biogen, FDA at odds over timing of crucial confirmatory trial of Alzheimer’s drug
Biogen and the Food and Drug Administration are at odds over the timing of a…
STAT+: Biogen isn’t worried about backlash to ‘bewildering’ price of Alzheimer’s drug
Amid a firestorm of controversy around its decision to charge $56,000 a year for an…
STAT+: Despite its high price tag, the new Alzheimer’s drug isn’t reigniting the drug pricing debate
WASHINGTON — It has all the makings of a bombastic drug pricing debate: a highly…
Elation, pride, and a slew of questions: Clinical trial participants reflect on their own complicated reactions to Aduhelm approval
For the roughly 3,500 people who volunteered as clinical trial participants for the Alzheimer’s therapy…
STAT+: Biogen’s big day is a Wall Street windfall for biotechs in Alzheimer’s
As Biogen soared Monday on the surprise Food and Drug Administration approval of its hotly…
An extra twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug
As if the saga of aducanumab needed another twist, the Food and Drug Administration tossed…
STAT+: Why Biogen may be sitting on the most lucrative product in pharmaceutical history
Biogen’s quest to win approval for a new Alzheimer’s disease treatment once seemed futile. Now…
STAT+: By approving Biogen’s Alzheimer’s drug, the FDA is shifting its rules. That is a giant risk
In order to approve a new Alzheimer’s treatment, the Food and Drug Administration is rewriting…
FAQs: What you need to know about the Alzheimer’s drug Aduhelm
The Food and Drug Administration on Monday approved Biogen’s new Alzheimer’s drug, a decision with…
Opinion: FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs
The Food and Drug Administration yanked the fight against Alzheimer’s out of the mire with…
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
The Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease…
A landmark Alzheimer’s drug approval would likely deepen racial inequities in dementia care
Come Monday, we should learn whether the Food and Drug Administration will approve the first…
What is a Silent Stroke?
A regular stroke is a 911 emergency. It is an interruption of blood flow to…
Ask The Doctor: Supplements For Brain Health, Oversleeping Dementia, Dyspepsia
Q. Should I take any vitamins or supplements for brain health? I want to do…
Research Roundup: June 2021
Med Diet May Boost Brain Function. Regular Med diet style eating is associated with better…
Opinion: Routine cognitive screening can help detect early signs of dementia
Both of us lost our dads to Alzheimer’s disease, and both of our families carried…
Proton Pump Inhibitor (PPI) Side Effects
PPIs are medications used to reduce stomach acid and heartburn. Heartburn is the burning pain…
Side Effects of Statins and Dementia
Based on some early studies, the Food and Drug Administration (FDA) added a warning on…
STAT+: Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500
Good morning, everyone, how are you today? We are doing just fine, thank you, as…
Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims
Six patients with dementia traveled to Mexico last year to be injected with a gene…
Newsbriefs: Power Cycling Increases Muscle Mass and Power; Colorful Produce May Reduce Alzheimer’s Risk; Blood Protein Signatures to Assess Wellness
Power Cycling Increases Muscle Mass and Power Compared to slow velocity training, research has shown…
Cochlear Implants May Help You Hear Better
Nearly 25 percent of U.S. adults ages 65 to 74 and 50 percent of those…